Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: PTCT stock price vs AXP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AXP's multiple
Needs AXP P/E.
Implied fair value · at PTCT's multiple
Needs PTCT P/E.
Live quote
Price unavailable
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency edge
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: PTCT FY 2025 (ended Dec 31, 2025) · AXP FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
-$676.41M
Price / tangible book
—
Price / book
—
Return on equity
-332.5%
Return on assets
23.5%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity
$28.51B
Price / tangible book
—
Price / book
—
Return on equity
32.4%
Return on assets
3.6%
Efficiency ratio
72.2%
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
PTC Therapeutics, Inc. · implied price per share
Bear
$79.76
Base
$93.84
Bull
$107.91
AMERICAN EXPRESS CO · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-2.79x
1.73x
Net debt / EBITDA
Leverage against operating earnings
-1.83x
1.97x
Cash and equivalents
Liquid reserves on the balance sheet
$1.95B
$1.40B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
VERTEX PHARMACEUTICALS INC / MA
PTCT vs VRTX
Sarepta Therapeutics, Inc.
PTCT vs SRPT
BIOMARIN PHARMACEUTICAL INC
PTCT vs BMRN
ALNYLAM PHARMACEUTICALS, INC.
PTCT vs ALNY
Visa Inc.
PTCT vs V
Mastercard Incorporated
PTCT vs MA
CAPITAL ONE FINANCIAL CORP
PTCT vs COF
PayPal Holdings, Inc.
PTCT vs PYPL
Synchrony Financial
PTCT vs SYF
$572.04M
$57.76B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
